Literature DB >> 3032095

Organization of two sulfonamide resistance genes on plasmids of gram-negative bacteria.

G Swedberg.   

Abstract

The organization of two widely distributed sulfonamide resistance genes has been studied. The type I gene was linked to other resistance genes, like streptomycin resistance in R100 and trimethoprim resistance in R388 and other recently isolated plasmids from Sri Lanka. In R388, the sulfonamide resistance gene was transcribed from a promoter of its own, but in all other studied plasmids the linked genes were transcribed from a common promoter. This was especially established with a clone derived from plasmid R6-5, in which transposon mutagenesis showed that expression of sulfonamide resistance was completely dependent on the linked streptomycin resistance gene. The type II sulfonamide resistance gene was independently transcribed and found on two kinds of small resistance plasmids and also on large plasmids isolated from clinical material.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3032095      PMCID: PMC174711          DOI: 10.1128/AAC.31.2.306

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

1.  Some observations on linkage effects in genetic recombination in Escherichia coli K-12.

Authors:  R C CLOWES; D ROWLEY
Journal:  J Gen Microbiol       Date:  1954-10

2.  Segregation of New Lysogenic Types during Growth of a Doubly Lysogenic Strain Derived from Escherichia Coli K12.

Authors:  R K Appleyard
Journal:  Genetics       Date:  1954-07       Impact factor: 4.562

3.  Prolonged incubation in calcium chloride improves the competence of Escherichia coli cells.

Authors:  M Dagert; S D Ehrlich
Journal:  Gene       Date:  1979-05       Impact factor: 3.688

4.  Sulfonamide resistance mechanism in Escherichia coli: R plasmids can determine sulfonamide-resistant dihydropteroate synthases.

Authors:  E M Wise; M M Abou-Donia
Journal:  Proc Natl Acad Sci U S A       Date:  1975-07       Impact factor: 11.205

5.  Translocation of a plasmid DNA sequence which mediates ampicillin resistance: molecular nature and specificity of insertion.

Authors:  F Heffron; C Rubens; S Falkow
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

6.  Physical and genetic analysis of the Inc-W group plasmids R388, Sa, and R7K.

Authors:  J M Ward; J Grinsted
Journal:  Plasmid       Date:  1982-05       Impact factor: 3.466

7.  Characterization of Tn2411 and Tn2410, two transposons derived from R-plasmid R1767 and related to Tn2603 and Tn21.

Authors:  J Kratz; F Schmidt; B Wiedemann
Journal:  J Bacteriol       Date:  1983-09       Impact factor: 3.490

8.  Characterization of different plasmid-borne dihydropteroate synthases mediating bacterial resistance to sulfonamides.

Authors:  G Swedberg; O Sköld
Journal:  J Bacteriol       Date:  1980-04       Impact factor: 3.490

9.  Nucleotide sequence of the rightward operator of phage lambda.

Authors:  T Maniatis; A Jeffrey; D G Kleid
Journal:  Proc Natl Acad Sci U S A       Date:  1975-03       Impact factor: 11.205

10.  Molecular nature of a streptomycin and sulfonamide resistance plasmid (pBP1) prevalent in clinical Escherichia coli strains and integration of an ampicillin resistance transposon (TnA).

Authors:  U van Treeck; F Schmidt; B Wiedemann
Journal:  Antimicrob Agents Chemother       Date:  1981-03       Impact factor: 5.191

View more
  12 in total

1.  Nosocomial spread of an amikacin resistance gene on both a mobilized, nonconjugative plasmid and a conjugative plasmid.

Authors:  J D Hopkins; A Flores; M del Pilar Pla; S Lester; T F O'Brien
Journal:  Antimicrob Agents Chemother       Date:  1991-08       Impact factor: 5.191

2.  RSF1010 and a conjugative plasmid contain sulII, one of two known genes for plasmid-borne sulfonamide resistance dihydropteroate synthase.

Authors:  P Rådström; G Swedberg
Journal:  Antimicrob Agents Chemother       Date:  1988-11       Impact factor: 5.191

Review 3.  Trimethoprim and sulfonamide resistance.

Authors:  P Huovinen; L Sundström; G Swedberg; O Sköld
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

4.  Analysis of the aac(3)-VIa gene encoding a novel 3-N-acetyltransferase.

Authors:  P N Rather; P A Mann; R Mierzwa; R S Hare; G H Miller; K J Shaw
Journal:  Antimicrob Agents Chemother       Date:  1993-10       Impact factor: 5.191

5.  Characterization of transposon Tn5086, carrying the site-specifically inserted gene dhfrVII mediating trimethoprim resistance.

Authors:  L Sundström; G Swedberg; O Sköld
Journal:  J Bacteriol       Date:  1993-03       Impact factor: 3.490

6.  Site-specific recombination promotes linkage between trimethoprim- and sulfonamide resistance genes. Sequence characterization of dhfrV and sulI and a recombination active locus of Tn21.

Authors:  L Sundström; P Rådström; G Swedberg; O Sköld
Journal:  Mol Gen Genet       Date:  1988-08

Review 7.  Transposon Tn21, flagship of the floating genome.

Authors:  C A Liebert; R M Hall; A O Summers
Journal:  Microbiol Mol Biol Rev       Date:  1999-09       Impact factor: 11.056

8.  Multidrug-resistant Pseudomonas aeruginosa strain that caused an outbreak in a neurosurgery ward and its aac(6')-Iae gene cassette encoding a novel aminoglycoside acetyltransferase.

Authors:  Jun-ichiro Sekiguchi; Tsukasa Asagi; Tohru Miyoshi-Akiyama; Tomoko Fujino; Intetsu Kobayashi; Koji Morita; Yoshihiro Kikuchi; Tadatoshi Kuratsuji; Teruo Kirikae
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

9.  Genetic analyses of sulfonamide resistance and its dissemination in gram-negative bacteria illustrate new aspects of R plasmid evolution.

Authors:  P Rådström; G Swedberg; O Sköld
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

10.  Integrons found in different locations have identical 5' ends but variable 3' ends.

Authors:  R M Hall; H J Brown; D E Brookes; H W Stokes
Journal:  J Bacteriol       Date:  1994-10       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.